Oral cancer referrals and the cost of missing time in primary care
Delayed recognition of oral lesions can turn a routine dental visit into a medicolegal complaint, and in some cases a later-stage cancer diagnosis. A September 2025 webinar led by Helen Kaney is built around that reality, drawing on MDDUS case experience and the pattern of negligence claims linked to failure or delay in referral. For general dental practice, the message is direct: oral cancer risk management begins long before a biopsy is ever arranged.
The session is aimed at dentists and dental care professionals working in primary care, where the first warning signs often appear as an ulcer, a patch of mucosal change, a lump, or a lesion that simply does not heal. The educational focus is not on rare specialist presentations but on the ordinary clinical encounters where concern can be dismissed too soon or where review intervals become a trap. In that setting, timing affects both prognosis and the legal defensibility of the care pathway.
One sentence captures the clinical stakes clearly: a lesion that should have been referred can become the central fact in a negligence claim.
What delayed diagnosis looks like in dental practice
The webinar is framed around common pitfalls rather than abstract theory. In everyday practice, the danger lies in normalising persistence: a lesion that lingers beyond the expected healing period, an ulcer that is reassured away without adequate examination, or a patient whose symptoms are attributed to trauma, denture irritation, or minor inflammation without proper follow-up. When the eventual diagnosis is oral cancer, those decisions are often reviewed in forensic detail.
Kaney’s background makes her perspective especially relevant. She trained first in dentistry, then in law, and later acted in clinical negligence and regulatory matters for doctors and dentists. That combination gives the webinar a practical lens: it is not merely about what should have been done in an idealised clinic, but about how documentation, communication, and referral thresholds are scrutinised when a case is examined after the fact.
The case-based approach is important because oral cancer claims often turn on small details. Was the lesion measured? Was the site described precisely? Was the differential diagnosis recorded? Was the patient advised on what to look for, when to return, and why referral was recommended? In complaints work, those details can decide whether the record shows structured clinical judgement or an unsafe gap in care.
UK guidance, documentation, and the referral threshold
The learning outcomes centre on UK guidance for patients with oral ulceration and other oral lesions, together with the need for careful assessment and documentation. That is the clinical core of the webinar. Dentists are expected to distinguish self-limiting disease from pathology that demands escalation, and the threshold for referral must be low enough to prevent delay while still being based on a reasoned examination.
Oral lesions are deceptively common, but persistent ones are not benign by default. A lesion that fails to resolve, changes character, bleeds, becomes indurated, or is associated with unexplained pain should trigger concern. So should lesions in high-risk locations or in patients with relevant histories, although the webinar text does not specify any single risk profile. The practical problem is that malignancy can present without dramatic symptoms, which means visual inspection alone is not enough; pattern recognition, serial review, and clear safety-netting are part of the diagnostic process.
Good documentation does more than protect against an allegation. It shows that the clinician understood the lesion, considered the possibilities, and acted on them. In a subsequent review, a record that explicitly captures appearance, duration, symptoms, advice, and referral rationale becomes evidence of responsible care. A record that is thin, vague, or silent on follow-up can look very different when read through a negligence lens.
Why MDDUS case experience matters for dentists and DCPs
The webinar also addresses the types of cases MDDUS handles when a patient later receives a diagnosis of oral cancer after an alleged failure to refer. That claim pattern matters because it reflects a recurring clinical vulnerability in general practice rather than an isolated error. It also gives dentists and DCPs a realistic view of where complaints emerge: not only from missed disease, but from uncertainty that was never closed off with a clear plan.
In clinical terms, delay is harmful because oral malignancies can advance while symptoms remain nonspecific. In legal terms, delay is harmful because a preventable referral gap is easy to narrate after the diagnosis has been made. The same consultation may be judged very differently depending on whether the notes show a structured decision-making process or only a fleeting reassurance.
The webinar’s emphasis on common pitfalls suggests a training need that reaches beyond dentists alone. DCPs in general practice often see patients first, reinforce advice, or help with follow-up. Shared awareness of red-flag lesions, persistence, and escalation pathways can reduce the chance that an abnormal finding disappears between team members. A practice that treats referral as a team responsibility is less likely to lose momentum on a suspicious lesion.
CPD, professional standards, and the medicolegal frame
The session carries 1 hour of enhanced CPD and meets the General Dental Council’s development outcome A, with certification available to eligible attendees. Those details matter because oral cancer vigilance is not a niche skill. It sits squarely within the routine responsibilities of general dental practice, where early detection depends on competence, repetition, and disciplined follow-through.
Helen Kaney’s biography adds weight to the teaching. She spent years in general dental practice, worked in hospital settings, later qualified in law, and built substantial experience advising dentists across the UK, Ireland, and other jurisdictions. Her career trajectory mirrors the webinar’s central theme: diagnosing pathology is only one part of the job; documenting a defensible pathway is the other.
For clinicians, the most relevant lesson is not abstract risk aversion. It is the need to recognise when a lesion has crossed the line from watchful waiting to referral, and to make that decision visible in the notes. Oral cancer does not reward hesitation, and neither do the negligence claims that follow it. The unresolved question in many practices is not whether suspicious lesions should be referred, but how reliably that decision is recognised, recorded, and acted on before time is lost.